Stockreport

Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics

Tempus AI, Inc. - Class A  (TEM) 
PDF CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today report [Read more]